|Mr. Barry Morgan Smith||Chairman & CEO||3.26M||N/A||64|
|Mr. Jonathan N. Rubin||Chief Financial Officer||1.28M||1.22M||54|
|Mr. Daniel N. Gregoire||Gen. Counsel & Sec.||910.32k||N/A||62|
|Mr. Sanjeev K. Srivastava||Chief Exec. Officer of Magellan Healthcare||1.4M||N/A||51|
|Mr. Mostafa M. Kamal||Chief Exec. Officer of Magellan Rx Management||934.5k||N/A||37|
Magellan Health, Inc. engages in the healthcare management business in the United States. The company's Healthcare segment engages in the management of behavioral healthcare services and employee assistance program services; management of other specialty areas, including diagnostic imaging and musculoskeletal management; and the integrated management of physical, behavioral, and pharmaceutical healthcare for special populations comprising individuals with serious mental illness, dual eligibles, long-term services and supports, and other populations with unique and often complex healthcare needs. This segment provides its healthcare services through its comprehensive network of medical and behavioral health professionals, clinics, hospitals, and ancillary service providers. Its Pharmacy Management segment offers products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. This segment offers pharmacy benefit management services, pharmacy benefit administration for state Medicaid and other government sponsored programs; pharmaceutical dispensing operations; clinical and formulary management programs; medical pharmacy management programs; and programs for the management of specialty drugs that treat complex conditions. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, and third party administrators. Magellan Health, Inc. was founded in 1969 and is based in Scottsdale, Arizona.
Magellan Health, Inc.’s ISS Governance QualityScore as of January 1, 2018 is 2. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 2; Compensation: 3.